BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 2540366)

  • 1. [A clinical study of fluconazole in pulmonary aspergillosis].
    Yoneda R
    Jpn J Antibiot; 1989 Jan; 42(1):40-6. PubMed ID: 2540366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical evaluation of fluconazole in patients with mycotic infection].
    Matsushima T; Ikeda H; Tomizawa S; Nakamura J; Adachi M; Kawanishi M; Tanabe J; Tano Y
    Jpn J Antibiot; 1989 Jan; 42(1):153-63. PubMed ID: 2540361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical efficacy of fluconazole in the patient with pulmonary mycosis].
    Lee Y; Shiota T; Ikeda S; Katsura A; Hanawa T; Yagi K; Kosaba S; Hatakenaka R; Matsubara Y; Ninomiya K
    Jpn J Antibiot; 1989 Jan; 42(1):138-43. PubMed ID: 2540359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The clinical study of fluconazole against pulmonary mycosis. Effects of fluconazole on pulmonary cryptococcosis and aspergillosis, and its pharmacokinetics in patients].
    Nakashima M
    Jpn J Antibiot; 1989 Jan; 42(1):127-37. PubMed ID: 2540358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Fluconazole treatment of systemic mycoses].
    Mori T; Matsumura M; Ebe T; Takahashi M; Kohara T; Inagaki M; Isonuma H; Hibiya I; Hamamoto T; Watanabe K
    Jpn J Antibiot; 1989 Jan; 42(1):55-62. PubMed ID: 2540368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of fluconazole (UK-49,858) against experimental aspergillosis and cryptococcosis in mice.
    Troke PF; Andrews RJ; Marriott MS; Richardson K
    J Antimicrob Chemother; 1987 May; 19(5):663-70. PubMed ID: 3038824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case of secondary invasive pulmonary aspergillosis originating from an aspergilloma, successfully treated with itraconazole].
    Nakagawa Y; Shimazu K; Ebihara M; Amann K
    Nihon Kokyuki Gakkai Zasshi; 1998 Mar; 36(3):294-8. PubMed ID: 9656680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Four cases of pulmonary aspergilloma successfully treated with drug therapy].
    Kawana A
    Jpn J Antibiot; 2000 Feb; 53(2):91-100; discussion 100-2. PubMed ID: 10896541
    [No Abstract]   [Full Text] [Related]  

  • 9. [A clinical evaluation of fluconazole in the treatment of deep mycosis].
    Yagi S; Watanabe M; Nakajima M; Tsukiyama K; Moriya O; Hino J; Niki Y; Soejima R
    Jpn J Antibiot; 1989 Jan; 42(1):144-52. PubMed ID: 2540360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic necrotizing pulmonary aspergillosis complicated by a cavitary lesion caused by Pulmonary Mycobacterium-avium complex disease.
    Kobashi Y; Yoshida K; Miyashita N; Niki Y; Matsushima T
    Intern Med; 2005 Mar; 44(3):246-50. PubMed ID: 15805716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary aspergillosis in mice: treatment with a new triazole SCH39304.
    Defaveri J; Salazar MH; Rinaldi MG; Graybill JR
    Am Rev Respir Dis; 1990 Sep; 142(3):512-5. PubMed ID: 2202244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of ER-30346, a novel oral triazole antifungal agent, in experimental models of aspergillosis, candidiasis, and cryptococcosis.
    Hata K; Kimura J; Miki H; Toyosawa T; Moriyama M; Katsu K
    Antimicrob Agents Chemother; 1996 Oct; 40(10):2243-7. PubMed ID: 8891122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of efficacy of voriconazole therapy in 2 patients with pulmonary fungus balls.
    Gutierrez F; Masia M; Ramos JM; Elia M; Rodriguez-Tudela JL; Cuenca-Estrella M
    Clin Infect Dis; 2005 Jun; 40(11):1706-7. PubMed ID: 15889381
    [No Abstract]   [Full Text] [Related]  

  • 14. [Invasive pulmonary aspergillosis caused by Aspergillus ochraceus].
    Wierzbicka M; Podsiadło B; Janczarski M
    Pneumonol Alergol Pol; 1997; 65(3-4):254-60. PubMed ID: 9489424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiological resolution of cavitating Aspergillus fumigatus infection following treatment with oral voriconazole in two lung transplant recipients.
    Zoumot Z; Carby M; Hall AV
    Transpl Int; 2006 Aug; 19(8):688-90. PubMed ID: 16827687
    [No Abstract]   [Full Text] [Related]  

  • 16. [Successful use of fluconazole against semi-invasive--pulmonary aspergillosis].
    Mizuguchi M; Nishi K; Amemiya T; Tachibana H; Ohka T; Kurumaya H; Fujimura M; Matsuda T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Jun; 35(6):645-9. PubMed ID: 9379561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical study of fluconazole on deep-seated fungal infections].
    Ikemoto H; Watanabe K; Mori T; Taniuchi A; Akahonai Y; Mikuni C; Yoshida K; Kasai M; Kawamura K; Yoshida T
    Jpn J Antibiot; 1989 Jan; 42(1):63-116. PubMed ID: 2540369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical efficacy of fluconazole in urinary tract fungal infections].
    Nito H
    Jpn J Antibiot; 1989 Jan; 42(1):171-8. PubMed ID: 2540364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical evaluation of 61 patients with pulmonary aspergilloma.
    Kawamura S; Maesaki S; Tomono K; Tashiro T; Kohno S
    Intern Med; 2000 Mar; 39(3):209-12. PubMed ID: 10772121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A multiple center clinical trial on fluconazole for deep-seated fungal infections].
    Liang D; Xu N; Zhang H
    Zhonghua Nei Ke Za Zhi; 1995 Dec; 34(12):823-6. PubMed ID: 8731861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.